New Search

If you are not happy with the results below please do another search

Search
Generic filters

50 search results for:

13

C-Suite shuffle: A2 Bio, Bayer, BioNTech and more

Bayer has really shaken up its C-suite, cutting its senior executive team by nearly half as part of a previously announced operating overhaul. In other news, the recently retired CEO of BioMarin joined the board of a bioinformatics AI firm, while a well-known former biopharma executive became a board member of a well-capitalized startup. Meanwhile, Dyne Therapeutics is losing its CEO to the investment world.